These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26874926)

  • 1. Medication-related osteonecrosis of the jaw; what should we do as prosthodontists?
    Kuroshima S; Kaku M; Matsuura T; Atsuta I; Ayukawa Y; Sawase T
    J Prosthodont Res; 2016 Oct; 60(4):229-230. PubMed ID: 26874926
    [No Abstract]   [Full Text] [Related]  

  • 2. A current update on osteonecrosis of the jaw and bisphosphonates.
    Arrain Y; Masud T
    Dent Update; 2011 Dec; 38(10):672-6, 678. PubMed ID: 22408887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the Jaw.
    Hamdy RC
    J Clin Densitom; 2017; 20(1):1-2. PubMed ID: 28259260
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteoporosis medications and your dental health.
    J Am Dent Assoc; 2011 Nov; 142(11):1320. PubMed ID: 22041419
    [No Abstract]   [Full Text] [Related]  

  • 5. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.
    Fusco V; Galassi C; Berruti A; Ciuffreda L; Ortega C; Ciccone G; Angeli A; Bertetto O
    J Clin Oncol; 2011 Jun; 29(17):e521-2; author reply e523-4. PubMed ID: 21537047
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB; O'Ryan F
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points.
    Rossi M; Gambino A; Cabras M; Alessio M; Fusco V
    Support Care Cancer; 2021 Aug; 29(8):4185-4186. PubMed ID: 33634351
    [No Abstract]   [Full Text] [Related]  

  • 11. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk?
    Sidhu HK
    Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: golimumab-related osteonecrosis of the jaw.
    Ghosh YA; Pullara J; Rattan R; Melville JC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Nov; 136(5):e149-e152. PubMed ID: 37661466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Denosumab related osteonecrosis of the jaw: Unusual pattern with periosteal reaction.
    Tagliamento M; Boutros C; Viansone A; Brau JJ; Descols P
    Eur J Cancer; 2022 May; 166():33-37. PubMed ID: 35272085
    [No Abstract]   [Full Text] [Related]  

  • 15. [Osteonecrosis of the jaw].
    Drozdzowska B
    Endokrynol Pol; 2011; 62 Suppl 3():4-9. PubMed ID: 22161980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Medication-Related Osteonecrosis of the Jaw: Controversies in Causality and Therapy.
    Halpern LR; Adams DR
    Dent Clin North Am; 2024 Jan; 68(1):67-85. PubMed ID: 37951638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maxillar osteonecrosis related to denosumab. Evaluation of nine cases.
    Sánchez López JD; Cariati P; Pérez de Perceval Tara M
    Med Clin (Barc); 2020 Aug; 155(4):180-181. PubMed ID: 31427154
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab.
    Loyson T; Van Cann T; Schöffski P; Clement PM; Bechter O; Spriet I; Coropciuc R; Politis C; Vandeweyer RO; Schoenaers J; Dumez H; Berteloot P; Neven P; Nackaerts K; Woei-A-Jin FJSH; Punie K; Wildiers H; Beuselinck B
    Acta Clin Belg; 2018 Apr; 73(2):100-109. PubMed ID: 28693379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etiopathogenesis of medication-related osteonecrosis of the jaws: a review.
    Bassan Marinho Maciel G; Marinho Maciel R; Linhares Ferrazzo K; Cademartori Danesi C
    J Mol Med (Berl); 2024 Mar; 102(3):353-364. PubMed ID: 38302741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.